PhRMA and congressional Democrats file briefs to reverse court ruling on mifepristone

The Pharmaceutical Research and Manufacturers of America has waded into the mifepristone controversy by filing an amicus brief – along with other industry stakeholders – asking for a reversal of a lower court decision in Alliance for Hippocratic Medicine v. the U.S. Food and Drug Administration. More than 250 congressional Democrats have also filed a brief urging an appeals

Related Keywords

Texas ,United States ,America ,Jim Stansel ,Matthew Kacsmaryk ,Mike Kline Getty ,Justice Department ,Technology Association ,Reuters ,Us District Court ,Us Court ,National Association Of Manufacturers ,Jackson Women Health Organization ,Supreme Court ,Alliance For Hippocratic Medicine ,Drug Administration ,Consumer Healthcare Products Association ,Pharmaceutical Research ,Hippocratic Medicine ,Fifth Circuit ,New Orleans ,Advanced Medical Technology Association ,National Association ,Risk Evaluation ,Mitigation Strategies ,Health Organization ,Northern District ,Danco Laboratories ,Judge Matthew Kacsmaryk ,